Related Experiment Video
Updated: Jul 2, 2025

07:29
The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
Published on: March 8, 2019
10.8K
Pulmonary Artery Hypertension: Fifty Years Following Pneumonectomy in Infancy
Matthew Seplowe1, Ameesh Isath2, Liana Michaud1
1From the Department of Medicine, Westchester Medical Center, New York Medical College, Valhalla, NY.
Cardiology in Review
|February 27, 2024
Summary
Pulmonary hypertension (PH) can occur after lung removal. This case study shows improved PH symptoms in a patient over 50 years post-pneumonectomy using targeted therapy.
Area of Science:
- Cardiology
- Pulmonology
- Vascular Medicine
Background:
- Pulmonary hypertension (PH) is a serious vascular complication that can arise after major lung resection.
- Pneumonectomy, the removal of an entire lung, significantly increases the risk of developing PH and impacts functional status.
- Long-term consequences of pneumonectomy, including PH developing decades later, require careful consideration.
Purpose of the Study:
- To describe the diagnosis and management of moderate pulmonary hypertension (PH) in a patient presenting over 50 years after a unilateral pneumonectomy.
- To highlight the potential for symptom improvement in long-standing PH post-pneumonectomy with targeted treatment.
- To discuss the implications of delayed-onset PH following major lung resection.
Main Methods:
- Case report detailing the diagnostic process for moderate pulmonary hypertension (PH).
- Management strategies employed, including off-label use of WHO group 1 treatments.
- Long-term follow-up of a patient who underwent total unilateral pneumonectomy in infancy.
Main Results:
- Diagnosis of moderate pulmonary hypertension (PH) confirmed more than 50 years after unilateral pneumonectomy.
- Significant improvement in PH symptoms and functional status observed.
- Successful management achieved through off-label administration of WHO group 1 targeted therapy.
Conclusions:
- Pulmonary hypertension (PH) can manifest decades after pneumonectomy, significantly impacting patient health.
- Off-label use of WHO group 1 treatments may offer a viable therapeutic option for selected PH patients post-pneumonectomy.
- Early recognition and tailored management are crucial for improving outcomes in patients with delayed-onset PH.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
180
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
180
Pneumothorax-II
146
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
146
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
214
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
214
Pneumonia I: Introduction
238
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
238
Pneumothorax-I
208
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
208

